Lupin Limited announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone for extended-release injectable ...

CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, ...

Sandoz will commercialize Lupin's biosimilar ranibizumab in multiple regions, excluding Germany, with exclusive rights in most areas. Lupin retains responsibility for manufacturing and regulatory ...

In making one of the most unexpected reveals in the entirety of anime’s Hollywood history, original Hellboy screenwriter Peter Briggs has let slip that at around the same time he was penning the ...

Lupin has received approval from the Food and Drug Administration for loteprednol etabonate ophthalmic gel, 0.38%, which is the generic of Bausch & Lomb’s Lotemax SM Ophthalmic Gel. Lupin is the ...

The waters of a Texas lake remain shrouded in mystery as dozens of young men’s bodies continue to be pulled from the depths, putting a community on edge as rumors of a serial killer continue to swirl.

Lupin's Loteprednol Etabonate Ophthalmic Gel, 0.38% is FDA-approved for treating postoperative ocular inflammation and pain. The gel is bioequivalent to Bausch & Lomb’s Lotemax SM Ophthalmic Gel, with ...

July 1 (Reuters) - Indian drugmaker Lupin (LUPN.NS), opens new tab said on Tuesday it will spin off its consumer healthcare business, LupinLife Consumer Healthcare into a separate unit, effective July ...